Phase 2a proof-of-concept study of PXL770 in patients with type-2 diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2017
At a glance
- Drugs PXL 770 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Proof of concept; Therapeutic Use
- 21 Sep 2017 According to Poxel media release, company is planning to initiate this study in 2018.
- 29 Jul 2016 New trial record
- 12 Jul 2016 According to Poxel media release, this trial is expected to be conducted in 2017.